Skip to content

Clinical evaluation of Siddha drug Sanmuga mezhugu in low back ache (sciatica).

Phase II non randomized open clinical evaluation of Siddha drug "SANMUGA MEZHUGU" for vathathambam (sciatica) - in both gender age between 25 TO 60 years patients attending opd at AAGHIM attached with GSMC.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020779
Enrollment
20
Registered
2019-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Sanmuga mezhugu: 100mg twice a day with palm jaggery for 35 days with intermittent 7 days gap. Control Intervention1: nil: nil

Sponsors

Government Siddha medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having pain in the low back or leg Burning or tingling sensation present in the posterior and lateral aspect of the leg Weakness, numbness and difficulty in moving the leg or foot A constant pain on one side of the back A positive SLR test

Exclusion criteria

Exclusion criteria: Fracture of vertebrae Dislocation of vertebrae Deformities and congenital defects Known case of tuberculosis of spine Known case of neoplasm of spine Pregnancy and lactating women Multiple myeloma Patients of age below 25 above 60 years

Design outcomes

Primary

MeasureTime frame
Primary outcome of treatment is mainly assessed by reduction in clinical symptoms measured by using Roland-Morris disability scaleTimepoint: 35 days with intermittent 7 days gap

Secondary

MeasureTime frame
Secondary outcome of treatment is assessed by comparing the safety parameters before and after treatmentTimepoint: 35 days with intermittent 7 days gap

Countries

India

Contacts

Public ContactDr SUSHMITHA S

Government Siddha medical college

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026